Group 1 - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any false records or misleading statements [2][8] - The third quarter financial statements have not been audited [3] - The company plans to hold a performance briefing on November 3, 2025, to discuss the third quarter results and address investor questions [18][19] Group 2 - The company has appointed Xinyong Zhonghe Accounting Firm as the auditor for the 2025 financial year, which has a strong track record and investor protection capabilities [24][25] - The audit fee for this period is set at 1.35 million yuan, consistent with the previous year's fee [34][35] - The board of directors approved the appointment of the auditing firm with unanimous support [36][38] Group 3 - The fourth extraordinary general meeting of shareholders is scheduled for November 14, 2025, with both on-site and online voting options available [39][40] - Shareholders must register to attend the meeting, and specific procedures for registration are outlined [50][56] - The meeting will address previously approved resolutions from the board of directors [42][43]

Core Viewpoint - The company has released its third-quarter financial report for 2025, highlighting significant changes in financial metrics and the election of a new board of directors [12][8]. Financial Data Summary - The company reported a decrease in long-term receivables by 6.19 million yuan, a decline of 32.54%, primarily due to the recovery of post-sale rental deposits [5]. - Long-term prepaid expenses increased by 5.76 million yuan, up 43.86%, attributed to the rise in consulting and advisory fees [5]. - Other non-current assets rose by 107.48 million yuan, an increase of 78.59%, due to increased prepayments for equity investments [5]. - Long-term borrowings increased by 279.47 million yuan, a rise of 34.84%, as the company took out new long-term loans after repaying short-term borrowings [5]. - Long-term payables decreased by 59.06 million yuan, down 57.67%, due to the payment of payables due within one year [5]. Profit and Loss Summary - Financial expenses decreased by 27.38 million yuan, a decline of 31.09%, mainly due to lower interest expenses on bank loans [6]. - Investment income fell by 45.85 million yuan, a decrease of 80.05%, due to dividends received from a subsidiary [6]. - Credit impairment losses decreased by 8.16 million yuan, a decline of 438.13%, as the company reversed bad debt provisions [6]. - Operating income decreased by 2.06 million yuan, down 37.14%, due to a reduction in non-recurring income [6]. - Operating expenses decreased by 42.69 million yuan, a decline of 83.93%, primarily due to compensation payments made by a subsidiary [6]. Shareholder Information - The company held its second extraordinary general meeting of 2025 on July 30, where the election of the ninth board of directors was approved [8]. - The new board consists of 11 members, with a term of three years starting from the date of approval [8]. Audit Firm Appointment - The company plans to reappoint Lixin Certified Public Accountants as the auditor for the 2025 financial report, which complies with relevant regulations [22][23]. - Lixin has a strong track record, with 2,498 registered accountants and a revenue of 4.748 billion yuan in 2024 [24][25]. - The company also intends to appoint Zhongshunzhonghuan Certified Public Accountants for internal control audits for 2025, which has a solid reputation and experience in the industry [35][36]. Upcoming Shareholder Meeting - The company will hold its third extraordinary general meeting on November 11, 2025, to discuss various proposals, including the reappointment of audit firms [52][53].

Core Points - The annual compliance review for Nasdaq-listed companies is crucial for ensuring adherence to listing rules, SEC regulations, and maintaining investor trust [2] - The review focuses on the authenticity of financial reports, effectiveness of corporate governance, compliance with information disclosure, and soundness of internal controls [2] Financial Reporting and Audit Compliance - Nasdaq requires companies to submit independently audited annual reports (Form 10-K), emphasizing the authenticity and transparency of financial statements [2] - Key areas of focus include financial statement audits, compliance with the Sarbanes-Oxley Act (SOX), and consistency of financial data [3] Corporate Governance and Board Compliance - Nasdaq rules impose strict requirements on corporate governance, with annual reviews focusing on board composition and independence, executive compensation, and shareholder rights [2][3] - The majority of board members must be independent, and the audit committee must consist entirely of independent directors, with at least one possessing financial expertise [3] Information Disclosure and Transparency - Nasdaq emphasizes timely, accurate, and complete information disclosure, with annual reviews covering annual reports (Form 10-K) and proxy statements [4] - Companies must ensure timely submission of Form 8-K for significant events, avoiding delays or omissions [4] Internal Control and Risk Management - The annual review assesses the overall risk management framework, including key business process controls and risk management policies [6] - Companies must disclose major risks and their mitigation strategies, with auditors evaluating management's ability to identify and respond to risks [7] Listing Rules and Ongoing Compliance - Nasdaq maintains strict ongoing listing requirements, with annual reviews verifying compliance with listing standards and other obligations [6] - Companies must ensure compliance with regulations such as anti-money laundering (AML) and data privacy laws [7] Special Considerations for Certain Company Types - Foreign Private Issuers can use IFRS for financial reporting but must disclose differences from US GAAP [7] - Emerging Growth Companies may simplify certain disclosures but must still meet basic financial and governance requirements [7]

Core Viewpoint - The company has undergone significant changes in its shareholder structure and management, while also planning to continue its financial support to subsidiaries and maintain its auditing arrangements for the upcoming year [7][11][54]. Group 1: Company Overview - The company is named Shenzhen Lihe Science and Technology Co., Ltd. and is listed under the stock code 002243 [1]. - The company has not changed its controlling shareholder or actual controller during the reporting period [4][5]. Group 2: Financial and Operational Updates - The company plans not to distribute cash dividends or issue bonus shares for the reporting period [2]. - The company issued a total of RMB 700 million in medium-term notes with an interest rate of 2.18% [9]. - The company approved a financial assistance plan to provide up to RMB 640 million to its wholly-owned subsidiary Guangzhou Lihe Science and Technology Center [22]. Group 3: Shareholder Structure Changes - The company announced a change in the upper shareholder structure of its controlling shareholder, Shenzhen Qingyan Investment Holdings Co., Ltd., which was transferred to the Shenzhen Municipal Government State-owned Assets Supervision and Administration Commission [7][10]. - The transfer of 100% equity of the controlling shareholder was completed without affecting the company's governance structure [11]. Group 4: Management Changes - The company appointed Xu Anbi as the new general manager after the resignation of He Zhen, who will continue as chairman [8][12]. - The company also elected Yang Gaoyu as an independent director following the resignation of Zhang Hanbin [12]. Group 5: Audit and Compliance - The company has proposed to continue using the auditing services of Deloitte Touche Tohmatsu Certified Public Accountants for the year 2025, with an expected audit fee of RMB 1.7 million [54][55]. - The audit committee and supervisory board have reviewed and approved the decision to retain the auditing firm, ensuring compliance with relevant regulations [66].

Meeting Details - The 19th meeting of the third Supervisory Board of Jiangsu Haoaobo Biopharmaceutical Co., Ltd. was held on August 13, 2025, with all three supervisors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality and validity of the resolutions [1] Financial Report Review - The Supervisory Board reviewed the company's 2025 semi-annual report, confirming that its preparation and review procedures comply with relevant laws and internal management regulations [1] - The report accurately reflects the company's financial status and operating results for the first half of 2025, with all members of the Supervisory Board ensuring the information disclosed is true, accurate, and complete [1] Fund Management - The Supervisory Board assessed the management of raised funds, confirming compliance with the regulations governing the management of raised funds and the company's fundraising management system [2] - The company has stored and utilized the raised funds in a dedicated account, with no violations or damages to the interests of the company and its shareholders [2] Auditor Appointment - The Supervisory Board approved the appointment of Ernst & Young Hua Ming LLP as the auditing firm for the company's 2025 financial report and internal control audit, citing their qualifications and experience [3] - The resolution received unanimous approval from all supervisors, with 100% of the voting rights in favor [3]

Group 1 - The company is holding its second extraordinary general meeting of shareholders for 2025 on July 31, 2025, at 14:30, located at the Qulian Industrial Park, Hangzhou [5][6] - Shareholders and their representatives must register for the meeting by providing identification and relevant authorization documents, and only registered participants can vote [2][3] - The voting process will combine on-site and online voting, with each share granting one vote, and improper ballots will be considered as abstentions [3][5] Group 2 - The company proposes to reappoint Rongcheng Certified Public Accountants (Special General Partnership) as the auditing firm for the 2025 financial report and internal control, with an audit fee of 750,000 RMB [7][8] - Rongcheng Certified Public Accountants has a long history in the industry, originally established in 1988, and has been involved in auditing for numerous listed companies [8][9] - The auditing firm has been involved in 518 listed companies' annual report audits in 2024, with a total audit fee of approximately 620 million RMB [9]

Core Viewpoint - The company, Qingdao Inpace Health Technology Co., Ltd., has announced the reappointment of Heshin Accounting Firm as its auditor for the year 2025, ensuring the continuity of its auditing services and compliance with regulatory requirements [9][10][19]. Financial Data - The first quarter report for the company has not been audited [8]. - The company has repurchased 1,256,700 shares, accounting for 0.85% of the total share capital as of the reporting period [5]. Shareholder Information - The company has confirmed that there are no changes in the major shareholders and their shareholding status compared to the previous period [6]. Audit Firm Information - Heshin Accounting Firm has been selected for reappointment, with an audit fee of 850,000 yuan and an internal control audit fee of 280,000 yuan, remaining the same as the previous year [10][17]. - The firm has a total of 45 partners and 254 registered accountants, with 139 of them having signed audit reports for securities services [11]. - The firm has not faced any criminal penalties or disciplinary actions in the last three years [13][15]. Audit Committee and Board Decisions - The audit committee has reviewed and approved the reappointment of Heshin Accounting Firm, emphasizing its qualifications and independence [18]. - The board of directors unanimously approved the proposal to reappoint the audit firm, which will be subject to shareholder approval [19].

Group 1 - The audit committee of Zhejiang Changcheng Electric Technology Co., Ltd. consists of three members, including independent directors and a board member, with the chairman being a qualified independent director [1][3] - The audit committee held multiple meetings during the reporting period, approving key documents such as the 2023 annual report, financial settlement report, and internal control evaluation report [1][2] - The committee actively communicated with Tianjian Accounting Firm to establish the audit plan for the 2024 financial report and ensured the audit was completed smoothly [3][4] Group 2 - The audit committee reviewed quarterly, semi-annual, and annual financial reports, confirming no significant accounting errors or fraud related to financial reporting [3][4] - The financial reports were prepared in accordance with accounting standards and reflected the company's financial status, operating results, and cash flow accurately [4] - The committee emphasized the importance of internal control systems and provided guidance for their implementation, ensuring they align with the company's scale, business scope, and risk levels [4][5] Group 3 - The audit committee effectively supervised external audits and guided internal audit work, ensuring the accuracy and completeness of financial reports [5] - The committee plans to continue enhancing its supervisory functions, focusing on internal control systems, audit quality, and risk management [5]

新疆塔里木农业综合开发股份有限公司 审计委员会对会计师事务所履行 ( 监督职责情况的报告 (一) 会计师事务所基本情况 大信会计师事务所(特殊普通合伙)（以下简称"大信"）成立 于 1985年,2012年 3 月转制为特殊普通合伙制事务所,总部位于北 京,注册地址为北京市海淀区知春路 1 号 22 层 2206。大信在全国设 有 33 家分支机构,在香港设立了分所,并于 2017年发起设立了大信 国际会计网络,目前拥有美国、加拿大、澳大利亚、德国、法国、英 国、新加坡等 38 家网络成员所。大信是我国最早从事证券服务业务 的会计师事务所之一,首批获得H 股企业审计资格,拥有近 30年的 证券业务从业经验。 首席合伙人为谢泽敏先生。截至 2023年 12月 31日,大信从业 人员总数 4001人,其中合伙人 160人,注册会计师 971人。注册会 计师中，超过 500 人签署过证券服务业务审计报告。 (二)续聘会计师事务所履行的程序 根据《国有企业、上市公司选聘会计师事务所管理办法》《上海 证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引 第 1 号一规范运作》等规定和要求,新疆塔里木农业综合开发股 ...